Royal Philips’ seventh annual Future Health Index report paints a picture of health care systems in mid-transformation but cautions that digital tools must fully serve health care practitioners and not add to their daily burden.
Digitally-enabled technologies and services are the central plank on which health care transformation is being built.
But meeting the demands and expectations of all stakeholders is a more nuanced task than the pioneering system architects thought,...
Many assets do not meet their pre-launch predictions, either exceeding or falling short of their forecast sales. In this article, In Vivo highlights several historic examples and the factors that influenced their unexpected performance.
In Vivo spoke with Edward Ahn, CEO of Medipost, a Korean company that has developed stem cell therapies from cord blood, on how they are working across regulatory markets to provide a novel treatment for degenerative diseases.
Leading industry experts have spoken to In Vivo about how investment, a change in mindset and a fresh approach to policy may allow Italy to kick-start its biotech ecosystem.
